Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
CECERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc. (CERO)

Other OTC · Currency in USD
$0.01 ▼ 0.00 (-1.96%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.01
Open
$0.00
Day's Range
$0.00 – $0.01
52 Week Range
$0.00 – $2.00
Volume
1,009
Avg. Volume
679,026
Market Cap
$358.16K
Beta (5Y Monthly)
0.16
PE Ratio (TTM)
--
EPS (TTM)
-$0.39
Earnings Date
Dec 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: CERo Therapeutics Holdings, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
8
CEO
Christopher Ehrlich
Website
cero.bio

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.

Earnings

Next report: Wed, Dec 2, 2026
EPS estimate -$0.43
DateEst.Actual
Aug 14, 2026-$0.80-$0.54Beat
May 15, 2026-$0.80-$0.20Beat
Feb 25, 2026-$0.75-$0.75Beat
Nov 19, 2025-$0.76-$9.10Miss
Aug 22, 2025-$124.26-$61.71Beat
May 15, 2025-$75.50-$119.20Miss

Analyst view

Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on CERO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.